ILMN  valuation analysis

Name: Illumina Inc
Description: Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 05, 2022
Market cap: $38.54B (197th)
Sales(TTM): $4.66B (538th)
Earnings(TTM): $700.00M (429th)

FFER: 3.54 (why)
Actual price: $242.40
FFEThis is Illumina Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $68.55
Quantile: ILMN is very expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
  • Illumina Inc's operating income decreased from $584.00M to -$133.00M in the last year.
Earnings / MarketCap
Illumina Inc
"Diagnostics & Research" industry
Sales / MarketCap
Illumina Inc
"Diagnostics & Research" industry
Book / MarketCap
Illumina Inc
"Diagnostics & Research" industry
Equity / Assets
Illumina Inc
"Diagnostics & Research" industry